Bulletin 118 | Matt Fletcher, John Roberts, Dan Ryan
COVID-19 is still one of the hottest topics for scientific papers and articles. The COVID‑19 Actuaries Response Group provides a regular fortnightly update with a summary of the key papers and analyses that we’ve looked at recently.
In this issue, we look at:
- Pfizer vaccine authorised in the USA for children aged 12-15
- Lives saved from vaccines
- Take-up rates
- Pfizer vaccine efficacy and delaying the second doses
- Variants of concern – prevalence and genetic differences
- Modelling the release of restrictions
- COVID-19 impact on care homes
- OPENSAFELY analysis on ethnic groups
- ONS and REACT data
- beer and crisps